Medtronic Earnings, Revenue Beat in Q1 By Investing.com
© Reuters. Medtronic Earnings, Revenue Beat in Q1
Investing.com – Medtronic (NYSE:) reported on Tuesday first quarter that beat analysts’ forecasts and revenue that topped expectations.
Medtronic announced earnings per share of $1.41 on revenue of $7.99B. Analysts polled by Investing.com anticipated EPS of $1.32 on revenue of $7.87B.
Medtronic shares are up 9% from the beginning of the year, still down 2.95% from its 52 week high of $132.39 set on August 2. They are under-performing the S&P 500 which is up 19.26% from the start of the year.
Medtronic follows other major Healthcare sector earnings this month
Medtronic’s report follows an earnings beat by Pfizer on July 28, who reported EPS of $1.07 on revenue of $18.98B, compared to forecasts EPS of $0.9705 on revenue of $18.71B.
Novo Nordisk ADR had beat expectations on August 4 with second quarter EPS of $0.8379 on revenue of $5.26B, compared to forecast for EPS of $0.7823 on revenue of $5.16B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
